Anti-Covid drug molnupiravir
vendredi 31 décembre 2021 à 11:51The anti-Covid drug molnupiravir has the potential to encourage the development of new variants.
Only testing it in practice would show whether this happens or not; but if does, the result could be a disaster.
Since the Pfizer treatment is more effective and does not have this risk, we should not use molnupiravir.